UK guidelines for the systemic treatment of renal cell carcinoma.
There have been recent significant improvements in treatment options for patients with advanced renal cell carcinoma. This article presents UK consensus guidelines on the use of systemic therapies for this poor prognosis disease.
Nathan
Paul
P
Mount Vernon Cancer Centre, Northwood, Middlesex.
Wagstaff
John
J
Porfiri
Emilio
E
Powles
Tom
T
Eisen
Tim
T
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D011379:Prognosis; D006113:United Kingdom
D000970:Antineoplastic Agents